Ally Bridge Group is a global healthcare investment management firm focused on high-impact life science innovation. Founded in 2013 by Frank Yu, the firm invests across private and public markets, utilizing long-biased strategies to support life science advancements.
Focus Areas
Investment Types
Notable Investments
